Wegovy contains semaglutide, a GLP-1 receptor agonist that represents the first FDA-approved medication specifically for chronic weight management
The short answer is nocollagen and semaglutide do not have direct drug-nutrient interactions, but timing and stomach capacity matter when managing appetite suppression
Tirzepatide is sold as Mounjaro for T2D and Zepbound for obesity in the US, and the two brands grew 110% and 123% to $7.41 billion and $4.26 billion, respectively, in the last quarter of 2025, year-on-year
Who it is for: Individuals seeking visible skin brightening, improved skin texture, and anti-ageing support particularly those with chronic sun exposure, post-acne hyperpigmentation, or dull, fatigued-looking skin during summer months